Business
Axe Compute, formerly Predictive Oncology, shifted its focus in late 2025 toward enterprise AI compute access and a digital asset treasury centered on Aethir token.
Axe Compute pivoted to AI compute and ATH treasury, while FY2025 net loss widened to $233.1M.
The read at a glance✓ Audited against SEC data
- Business mix — AI compute plus ATH treasury pivotNote
- Legacy revenue — Drug Discovery revenue was $84.8KWatch
- Profitability — Net loss widened to $233.1MWatch
- Balance sheet — Equity rebuilt to $47.7MNote
- Liquidity — Going-concern language remainsWatch
- Insiders — 0 buys / 0 sellsNote
- Accounting — No forensic flags in local bundleNote
Where the revenue comes from
Fiscal 2024, as Axe Compute Inc. reports it. History and quarterly detail are in the app.
- Drug Discovery Services$85K
Leadership changes
From Axe Compute Inc.'s own filings, the day they're filed.
- Josh Blacher · Chief Financial Officer · departureeff. 2026-05-18
- Jeremy Yaukey-Witter · Chief Financial Officer · appointmenteff. 2026-04-16
- Kyle Okamoto · President · appointmenteff. 2026-04-01
Latest filings
- 8-K · Company announcement2026-08-17
- 10-Q · Quarterly report2026-08-14
- 8-K · Company announcement2026-08-14
- 8-K · Company announcement2026-07-27
- 8-K · Company announcement2026-07-22
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Axe Compute Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.